Therapeutic targeting of N-cadherin is an effective treatment for multiple myeloma.
about
PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma.Resistin-Like Molecule-β Promotes Invasion and Migration of Gastric Carcinoma Cells.Sphingosine kinase 2 inhibition synergises with bortezomib to target myeloma by enhancing endoplasmic reticulum stress.Active enhancer and chromatin accessibility landscapes chart the regulatory network of primary multiple myeloma.
P2860
Therapeutic targeting of N-cadherin is an effective treatment for multiple myeloma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Therapeutic targeting of N-cadherin is an effective treatment for multiple myeloma.
@en
type
label
Therapeutic targeting of N-cadherin is an effective treatment for multiple myeloma.
@en
prefLabel
Therapeutic targeting of N-cadherin is an effective treatment for multiple myeloma.
@en
P2093
P2860
P50
P356
P1476
Therapeutic targeting of N-cadherin is an effective treatment for multiple myeloma
@en
P2093
Annie W S Chow
Chee Man Cheong
Duncan Hewett
Orest W Blaschuk
P2860
P304
P356
10.1111/BJH.13596
P407
P577
2015-07-20T00:00:00Z